Health Canada approves Jemperli combo to treat dMMR/MSI-H endometrial cancer
The approval was supported by interim analysis findings from Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO Phase 3 study in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Nov 23
The approval was supported by interim analysis findings from Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO Phase 3 study in…
17 Nov 23
DS-5670 is an mRNA vaccine against COVID-19 designed to produce antibodies against the receptor binding domain (RBD) of…
16 Nov 23
The primary focus of the combined entity's lead programmes will be on addressing presbyopia, the age-related decline in…
16 Nov 23
For the first time, 2- to 5-year-old patients with a certain type of cystic fibrosis could access cystic…
16 Nov 23
Execution of binding subsequent investment agreement regarding contemplated additional equity investment of $140M by AstraZeneca, previously announced on…
15 Nov 23
The new capabilities are expected to assist healthcare firms in bringing down inventory errors and increasing the effectiveness…
15 Nov 23
Ingenious insights democratised to support the unique needs of small and emerging companies, including those that focus on…
14 Nov 23
Under the 10-year IDIQ contract, GDIT will install a new cloud-based enterprise EHR system from Oracle Health to…
14 Nov 23
The proposed deal is expected to strengthen and distinguish Telix's position in providing patients with a range of…
14 Nov 23
First-in-class clinical trial in dry AMD with new drug specifically designed to inhibit inflammasome activation in the eye…